Abhishek Singh
Hematology & Oncology · Providence, RINPI 1285366807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations.
Across 92 payments — averaging $29.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$552
- AstraZeneca$382
- E.r. Squibb & Sons, L.L.C.$300
- Johnson & Johnson$259
- Grifols USA, LLC$237
- Bayer$166
- plus $851 from 17 others
What the payments were for
- Food & beverage$2,65497%
- Education$933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $552 |
| AstraZeneca(2 entities) | 13 | $382 |
| E.r. Squibb & Sons, L.L.C. | 13 | $300 |
| Johnson & Johnson(2 entities) | 3 | $259 |
| Grifols USA, LLC | 5 | $237 |
| Bayer | 7 | $166 |
| Sanofi-aventis U.S. LLC | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 2 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| GSK | 4 | $72 |
| Alnylam Pharmaceuticals Inc. | 3 | $64 |
| Amgen | 2 | $50 |
| Fresenius Kabi USA, LLC | 2 | $48 |
| Pfizer | 2 | $42 |
| Boehringer Ingelheim | 2 | $39 |
| Merck | 1 | $35 |
| Seagen Inc. | 1 | $30 |
| Incyte Corporation | 1 | $29 |
| Geron Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Alcresta Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,747 in reported general payments places this provider in the 65th percentile of 68 hematology & oncology providers in Rhode Island.
Other hematology & oncology in Providence
- William SikovProvidence$156K
- Ritesh RathoreProvidence$148K
- Anthony MegaProvidence$65K
- Adam OlszewskiProvidence$63K
- Hina KhanProvidence$34K
- Peter BarthProvidence$29K
- Thomas OllilaProvidence$19K
- John ReaganProvidence$18K
- Jennifer GassProvidence$16K
- Matthew HadfieldProvidence$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.